Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-108153

SVP, Head of Finance & Admin. sold 1,390 shares at $34.55 ($48,025)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Scalzo Richard William SVP, Head of Finance & Admin. 2024-09-18 Sale 10b5-1 −1,390 $34.55 $48,025 98,568 D
Open-market sales · 1,390 sh · avg $34.55 · $48,025
Loading xslF345X05/ownership.xml…